Pirfenidone package insert pdf

In a singledose study, pirfenidone was coadministered with fluvoxamine 50 mg at bedtime for 3 days. Take pirfenidone capsules at around the same times every day. Before you start esbriet, your doctor should do certain blood tests to check how your liver is. Provides access to the latest drug monographs submitted to the food and drug administration fda. The drug substance pirfenidone is an achiral, nonhygroscopic white to pale yellow powder. Pirfenidone is known to cause photosensitivity reactions, rash, pruritus and dry skin. Concomitant treatment with nintedanib and pirfenidone was investigated in. Esbriet pirfenidone may help preserve more of your lung function by slowing disease progression. Pirfenidone is an oral antifibrotic agent that has been shown to reduce the decline in lung function in patients with idiopathic pulmonary fibrosis ipf. Patient information esbriet es breeet pirfenidone capsules and filmcoated tablets what is esbriet. Development history and fda approval process for esbriet date. Data sources include ibm watson micromedex updated 4 may 2020, cerner multum updated 4 may 2020.

Since its discovery as an antifibrotic agent in a hamster model of bleomycininduced pulmonary fibrosis, pirfenidone has been clinically evaluated for its safety and efficacy in numerous disorders such as idiopathic pulmonary fibrosis, multiple sclerosis, primary. Mar 21, 2014 because the concentration of pirfenidone required for photogenotoxicity was near the upper limit estimated from pharmacokinetics in healthy humans, a warning for an increased risk of skin cancer is described in the package insert supplied with pirfenidone in japan. The safety of pirfenidone has been evaluated in more than 1400 subjects with over 170 subjects exposed to pirfenidone for more than 5 years in clinical trials. Esbriet is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis ipf. Information for the user esbriet 267 mg hard capsules pirfenidone read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Nonformulary pirfenidone esbriet will be covered for 12 months on the prescription drug benefit when the following criteria are met.

Pirfenidone side effects, dosage, interactions drugs. Esbriet is indicated for the treatment of idiopathic pulmonary fibrosis ipf. Please see full prescribing information, including patient information, for. Through the special access scheme sas of australia, pirfenidone has been occasionally prescribed usually through the requests of respiratory specialists to supply on a named patient basis or to specified patients who were participants in clinical trials. Download leaflet view the patient leaflet in pdf format. Read all of this leaflet carefully before you start taking this medicine because it contains important information for you. Surgery was performed after at least 2 weeks of administration of pirfenidone 1200 mgday.

Contains nonbinding recommendations draft guidance on pirfenidone. If concomitant use cannot be avoided, reduce pirfenidone dosage to 267 mg 1 capsule 3 times a day 1. Australian product information esbriet pirfenidone. This leaflet has been written to help you understand more about.

Esbriet pirfenidone dose, indications, adverse effects. This new drug application provides for the use of esbriet pirfenidone filmcoated tablets for. Data from trials with pirfenidone and nintedanib have shown these drugs to be generally well tolerated and reasonably safe, but significant side effects can occur table 3. Fdca for esbriet pirfenidone filmcoated tablets, 267 mg, 534 mg, and 801 mg. Benefits may vary based on contract, and individual member benefits must be verified. Discontinue fluvoxamine prior to initiation of pirfenidone.

Although lung function that is lost cannot be restored, treatment may help maintain more of your lung function by slowing the progression of the disease. Benefit determinations are based on the applicable contract language in effect at the time the services. Esbriet pirfenidone is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis ipf. If you have any further questions, ask your doctor or pharmacist. This chronic, progressive, fibrosing interstitial disease can be difficult to diagnoseand, even when identified, can limit life expectancy. Management of idiopathic pulmonary fibrosis in the elderly. Esbriet 267 mg hard capsules patient information leaflet. Safety and efficacy of pirfenidone in advanced idiopathic. For a complete listing, see the dosage forms, composition and. Get the details on each, including clinical trial results and prescribing information.

In a 1year clinical study, people who took esbriet had better breathing capacity. Geodon can also be used as maintenance treatment of bipolar disorder when added to lithium or valproate. Sections or subsections omitted from the full prescribing information are not listed. Martinez, md chief, division of pulmonary and critical care bruce webster professor of medicine joan and sandford weill department of medicine weill cornell medical college new yorkpresbyterian hospitalweill cornell medical center new york, ny. If patients experience significant adverse reactions ie, gastrointestinal, photosensitivity reaction, rash, consider temporary dosage reductions or therapy interruptions of pirfenidone to allow for resolution of symptoms. The potential for pirfenidone to inhibit pgp mediated transport of digoxin 5. Pdf pirfenidone for the treatment of idiopathic pulmonary. Clinical criteria initial authorization criteria 1. Esbriet tablets contain pirfenidone and the following inactive ingredients. The intent of the esbriet pirfenidone drug policy is to ensure appropriate selection of patients for therapy based on product labeling, clinical guidelines, and clinical studies. Australian public assessment report for pirfenidone. The medication must be prescribed by, or in conjunction with, a. Pristiq medication page for healthcare professionals to search for scientific information on pfizer medications.

In case of an overdose, call your doctor or poison control center right away or go to the nearest emergency room. Dailymed esbriet pirfenidone capsule esbriet pirfenidone. Esbriet pirfenidone is a tgfbeta synthesis inhibitor for the treatment of patients with idiopathic pulmonary fibrosis ipf. Pirfenidone esbriet national drug monograph february 2015. For a list of all side effects that have been reported, ask your doctor or pharmacist for the geodon professional package insert. If a dose of ofev is missed, the next dose should be taken at the next scheduled time. However, desvenlafaxine pristiq is the major active metabolite of venlafaxine. We also refer to our letter dated june 7, 2018, notifying you, under section 505o4 of the fdca, of new safety information that we believe should be included in the labeling for esbriet pirfenidone. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis. The purpose of this report is to describe the case of a 68yearold man who was treated for idiopathic pulmonary fibrosis ipf, a chronic and fatal lung disease that is characterized. Follow the directions on your prescription label carefully, and ask your doctor or pharmacist to explain any part you do not understand. Get medical help right away if you have any symptoms of liver damage, including. Highlights of prescribing information these highlights do not.

Here, we investigated the effects of pirfenidone against advanced ipf in a realworld setting. A phase 3 trial of pirfenidone in patients with idiopathic pulmonary fibrosis published correction appears in n engl j med. When starting a new medicine or making a change in dosage, it can take time for your body to adjust. Esbriet pirfenidone capsules and filmcoated tablets, for oral use initial u. The scar tissue thickens and becomes stiff or thick over time, which can make it harder for your lungs to work. Pirfenidone esbriet pulmonary fibrosis agents may be considered medically necessary when used for treatment of a confirmed diagnosis of idiopathic pulmonary fibrosis clinical policy. This material is provided for educational purposes only and is not intended for medical advice, diagnosis or treatment. A local search option of this data can be found here. Highlights of prescribing information these highlights do not include all the information needed to use esbriet safely and effectively. Pirfenidone in patients with idiopathic pulmonary fibrosis capacity. Also find the package insert, announcements, resources, and ways to connect with pfizer medical through a variety of channels. Department of health and human services food and drug administration silver spring md 20993 nda 208780.

The printed package leaflet of the medicinal product must state the. Esbriet is a prescription medicine used to treat people with a lung disease called idiopathic pulmonary fibrosis. Overdose experience reported with venlafaxine the parent drug of pristiq is presented below. Pirfenidone has not previously been submitted to the tga for approval within australia.

The scar tissue thickens and becomes stiff or thick. Cases of druginduced liver injury dili have been observed with esbriet. Esbriet pirfenidone for idiopathic pulmonary fibrosis. Prescriber is a pulmonologist and diagnosis of idiopathic pulmonary fibrosis ipf, confirmed by consensus at. Pdr drug summaries are concise pointofcare prescribing, dosing and administering information to help phsyicans more efficiently and accurately prescribe in their practice pdr s drug summaries are available free of charge and serve as a great resource for us based mds, dos, nps and pas in patient practice. Geodon is a type of prescription medicine called a psychotropic, also known as an atypical antipsychotic. Pirfenidone is used to treat a lung disease called idiopathic pulmonary fibrosis ipf. Esbriet pirfenidone dosing, indications, interactions. This draft guidance, when finalized, will represent the current thinking of the food and drug.

Idiopathic pulmonary fibrosis ipf is a chronic, progressive and lethal fibrosing interstitial pneumonia. Safety pooled safety data for pirfenidone is available from the capacity and ascend trials. Research open access a phase ii trial evaluating the efficacy. Increased systemic exposure to pirfenidone approximately fourfold in nonsmokers and sevenfold in smokers 1. Pirfenidone is indicated for the treatment of idiopathic pulmonary fibrosis ipf. Diagnosis of idiopathic pulmonary fibrosis confirmed by at least one of the following. Because the concentration of pirfenidone required for photogenotoxicity was near the upper limit estimated from pharmacokinetics in healthy humans, a warning for an increased risk of skin cancer is described in the package insert supplied with pirfenidone in japan. Benefit determinations are based on the applicable contract language in effect at the time the services were rendered. An official atsersjrsalat clinical practice guideline. Nov 09, 2018 pirfenidone is used to treat a lung disease called idiopathic pulmonary fibrosis ipf. But following a long history of triedandfailed treatments, there are now two promising options that are fda approved. Esbriet fda prescribing information, side effects and uses. Adverse drug reactions are defined as adverse events judged by the investigator as possibly or probably related to pirfenidone.

King te jr, bradford wz, castrobernardini s, et al. The median survival from the onset of the symptoms is 2. Diagnosis of idiopathic pulmonary fibrosis confirmed by. It is not known if esbriet is safe and effective in children. Microcrystalline cellulose, colloidal anhydrous silica, povidone, croscarmellose sodium, magnesium stearate, polyvinyl alcohol, titanium dioxide, macrogol polyethylene glycol, talc, and iron oxide. Esbriet pirfenidone information for healthcare professionals. Ipf causes scar tissue to form deep within your lungs. Side effects and safety data esbriet pirfenidone hcp. In the postmarketing period, nonserious and serious cases of dili, including severe liver injury with fatal outcome, have been reported. However, the effect of pirfenidone in patients with advanced ipf remains unclear. Learn about esbriet pirfenidone, a medicine for treating idiopathic pulmonary. Geodon can be used to treat symptoms of schizophrenia and acute manic or mixed episodes associated with bipolar disorder. If you have any further questions, ask your doctor or. To reduce the severity of these reactions, pirfenidone is to be taken after meals.

Safety of pirfenidone in patients with idiopathic pulmonary fibrosis. Esbriet pirfenidone rationale for inclusion in pa program. Pirfenidone is frequently associated with gastrointestinal side effects such as dyspepsia, nausea, gastritis, gastroesophageal reflux disease and vomiting. Ofev nintedanib capsules is an fdaapproved prescription medicine used. At the recommended dosage of 2403 mgday, 14% of patients discontinued pirfenidone because of an adverse event compared to 9. Elevated liver enzymes and druginduced liver injury dili. Pirfenidone is an orally available pyridone derivative that has antifibrotic and antiinflammatory effects. The prescriber will collect liver function tests on the schedule recommended in the package insert 4. Pirfenidone has been shown to have high permeability. The solubility and permeability profiles suggest that pirfenidone is a biopharmaceutics classification system bcs class 1 drug. The mechanism of pirfenidone has not been definitively established. Highlights of prescribing information these highlights do. Market exclusivities listed in the fda orange book drug database of pirfenidone with information and expiryexpiration dates.

83 1052 798 313 1029 1078 470 1097 940 337 956 514 1560 636 1118 833 1561 711 310 652 872 953 1172 808 1065 927 22 518 877 11 713 775 114 1035 877 1129 791 1456 123